Airborne Pharma: Drugmakers Race Against Tariffs

European drugmakers are expediting medicine shipments to the U.S. by air amid fears of impending tariffs following President Trump's announcements. Companies like UPS and DHL are involved, though the specifics remain undisclosed. The situation has impacted share prices of companies like Novo Nordisk and AstraZeneca.

As tensions rise over international trade tariffs, some European drugmakers are proactively shipping medicines by air to the United States. The measure comes amidst concerns that President Donald Trump’s tariff plans might extend to pharmaceuticals, potentially leading to supply chain disruptions.

Executives from two leading European pharmaceutical companies have admitted ramping up air shipments across the Atlantic, leveraging logistics giants such as UPS and DHL. While details remain sparse, the move is seen as part of a broader strategy to mitigate potential tariff impacts on the healthcare sector.

In recent months, fears of tariff-induced disruptions have not only affected the stock prices of major drug companies but have also sparked a similar expedited shipping trend across various industries. This heightened logistical activity reflects a cautious approach by industries heavily reliant on transatlantic trade.